Get the Daily Brief
Latest Biotech News
Moderna Wins UK Patent Battle Against Pfizer and BioNTech
The UK Court of Appeal affirmed the validity of Moderna's EP’949 patent on mRNA modifications used in COVID-19 vaccines, ruling that Pfizer and BioNTech’s Comirnaty vaccine infringes this key...
Regeneron's Q2 Achieves Revenue Growth Despite FDA Setbacks
Regeneron Pharmaceuticals reported a strong second quarter with revenues of $3.68 billion, surpassing analyst estimates despite regulatory challenges. The FDA delayed decisions on high-dose Eylea...
Clareo Biosciences Leverages PacBio Long Reads for Immune Receptor Profiling
Clareo Biosciences is advancing immunosequencing by applying Pacific Biosciences' HiFi long-read technology to capture comprehensive adaptive immune receptor repertoires at the DNA and RNA levels....
Syndeio Advances Synaptic Function Modulation with $90M Funding
Syndeio, a CNS biotechnology startup, has secured $90 million in funding to develop predictive pharmacology approaches that optimize synaptic transmission through precise dosing strategies. The...
Frazier Healthcare Launches $1.3 Billion Early-Stage Fund
Frazier Healthcare Partners has raised $1.3 billion for a new early-stage investment fund targeting innovative biotech companies. The fund will fuel advancements in discovery and clinical...
AI-Driven Synthetic Ligands Propel T-Cell Immunotherapy Innovations
Scientists have designed novel synthetic ligands activating the Notch signaling pathway via AI-driven protein engineering, enhancing T-cell development and function. Published in Cell, this...
Sava Technologies Raises $19 Million to Advance Biosensor Platform
Sava Technologies completed a $19 million Series A funding round to develop its multi-molecule biosensor capable of real-time biomarker detection beneath the skin. The investment will accelerate...
Bio-Rad Laboratories Ups Full-Year Guidance Amid Revenue Resilience
Bio-Rad Laboratories reported signs of stabilization and growth for 2025 after challenges from supply chain issues and a biopharma downturn. The company anticipates flat to 1% revenue growth...
AI in FDA Drug Approval: Elsa Generates Fake Studies
The FDA’s adoption of an AI tool named Elsa intended to streamline drug approval processes has raised significant concerns after reports revealed the system fabricates studies, a phenomenon known...
Lorlatinib Shows Real-World Efficacy in ALK-Positive NSCLC
A comprehensive multicenter real-world study conducted in China has confirmed the clinical effectiveness and safety profile of lorlatinib, a third-generation ALK tyrosine kinase inhibitor, in...
Regeneron Faces Regulatory Delays and FDA Rejection for Key Drugs
Regeneron Pharmaceuticals reported delays in FDA approval of its high-dose Eylea applications due to manufacturing issues at a Catalent facility, now owned by Novo Nordisk. These setbacks...
Alnylam's Amvuttra Launch Drives Market Cap Past $50 Billion
Alnylam Pharmaceuticals has surpassed a market capitalization of $50 billion following a robust launch of Amvuttra, its RNA interference therapy for transthyretin amyloidosis cardiomyopathy...
Moderna Wins UK Patent Fight with Pfizer and BioNTech
The UK Court of Appeals upheld the validity of Moderna’s key EP’949 patent covering modified mRNA technology used in COVID-19 vaccines, ruling that Pfizer/BioNTech’s Comirnaty vaccine infringes on...
Clareo Biosciences Uses PacBio HiFi Long-Reads for Immune Profiling
Clareo Biosciences is advancing immune receptor profiling by leveraging Pacific Biosciences’ HiFi long-read sequencing technology for comprehensive genomic characterization at DNA and RNA levels....
Artificial Intelligence Tools Revolutionize Medical Imaging and Proteomics
Researchers from the University of California San Diego and the Salk Institute have introduced AI innovations accelerating medical image analysis and microprotein discovery. A novel AI tool...
Advances in Cancer Immunotherapy and Tumor Biology
Several studies have revealed novel molecular and cellular mechanisms that enhance cancer therapy and illuminate tumor behavior. Notably, breast cancer cells have been shown to acquire...
Significant Funding and Strategic Moves in Biopharma Investment
Frazier has raised a $1.3 billion early-stage fund to boost investments in emerging biotech companies, reflecting strong investor confidence in innovation despite challenging macroeconomic...
Environmental Health and Disease Linkages Unveiled
New research explores critical intersections between environment and human health. A study demonstrated how wildfire smoke from Canadian fires severely degrades air quality across the U.S....
AI Challenges at FDA: Elsa’s Hallucinations Spark Concern
The Food and Drug Administration's AI tool, Elsa, intended to expedite drug approval processes, has come under scrutiny after reports revealed that it generates fabricated studies and...
Oncology Advancements: Immunotherapy and Metabolic Insights
Recent clinical and molecular studies have propelled oncology research forward with several key breakthroughs. A multicentre real-world analysis highlights Lorlatinib's efficacy in treating...